A recent report using patient-derived GBM samples and xenograft models of GBM also found significant associations between ErbB4 mRNA levels and tumorigenicity, proliferation, angiogenesis, and therapeutic response (10). This evidence concerns the gene ERBB4 and glioblastoma.